Evidence map›Paper›PMID 28441618›Full record

ArticlePsychiatry research2017

Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.

Amber L Bahorik, Catherine G Greeno, Gerald Cochran, Jack R Cornelius, Shaun M Eack

Abstract read
In one paragraph

Article in Psychiatry research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amber L BahorikUniversity of Pittsburgh, School of Social Work, Pittsburgh, PA, USA; University of California San Francisco, Department of Psychiatry, Weill Institute for Neurosciences, San Francisco, CA, USA; Kaiser Permanente Northern California Region, Division of Research, Oakland, CA, USA. Electronic address: amber.bahorik@ucsf.edu.
Catherine G GreenoUniversity of Pittsburgh, School of Social Work, Pittsburgh, PA, USA.
Gerald CochranUniversity of Pittsburgh, School of Social Work, Pittsburgh, PA, USA; University of Pittsburgh, Center for Pharmaceutical Policy and Prescribing, Pittsburgh, PA, USA.
Jack R CorneliusUniversity of Pittsburgh, Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.
Shaun M EackUniversity of Pittsburgh, School of Social Work, Pittsburgh, PA, USA; University of Pittsburgh, Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.
University of Pittsburgh · USUniversity of California, San Francisco · US

Funding

Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

This study examined the impact of substance use on intrinsic motivation and evaluated the association between intrinsic motivation and substance use recovery among individuals with schizophrenia. Alcohol and illicit drug use and intrinsic motivation were evaluated at baseline and 6-months for 1434 individuals with schizophrenia from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) using self-rated substance use assessments and a derived motivation measure from the Heinrichs-Carpenter Quality of Life Scale. Results revealed patients had moderate motivation deficits overall and a considerable number were using alcohol or illicit drugs at baseline (n=576; 40.2%). Regression models at baseline showed patients with low levels of motivation had higher odds of substance use and those who were using substances had greater motivation deficits. At 6-months, substance using patients continued to demonstrate greater motivation deficits; however, those with high levels of motivation exhibited a greater reduction in their use of substances. Findings remained significant after adjusting for clinical confounds and were consistent across any substance, alcohol, and cannabis use. Our results emphasize concerns about substance use compounding motivation deficits in schizophrenia, and suggest that disentangling the motivation-substance use relationship in schizophrenia may facilitate efforts aimed at ameliorating these challenges and improving outcomes.

Indexed as

MotivationSchizophrenic PsychologyAdultAlcohol-Related DisordersCognitive DysfunctionFemaleHumansMaleMiddle AgedSchizophreniaSubstance-Related DisordersIntrinsic motivationMotivation deficitsSchizophreniaSubstance useSubstance-using schizophrenia

Identifiers

PMID28441618
PMCPMC5503109
OpenAlexW2604335714

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.